Skip to main content
Mantapex
Will the FDA approve MDMA for PTSD?
MDMA for PTSDScience
Kalshi Active 6 markets·55¢ Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032?·$0 Total Volume·-- Liquidity·-- OI
6mo·Jan 8, 2027

Track your prediction positions

Connect your Kalshi account to track your contracts, P&L, and settlements.

Wide spread
No chart data available

Markets

6
Midomafetamine before Jan 2032
$0 vol
55% ▲0.0%
Midomafetamine before Jan 2031
$0 vol
54% ▲0.0%
Midomafetamine before Jan 2030
$0 vol
52% ▲0.0%
Midomafetamine before Jan 2029
$0 vol
47% ▲0.0%
Midomafetamine before Jan 2028
$0 vol
36% ▲0.0%
Midomafetamine before Jan 2032
No order book data available

If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2027, then the market resolves to Yes.

Series

KXFDAAPPROVE
View Full Series

Track Your Bets on Kalshi — and Everything Else

Create a free portfolio starting with your Kalshi positions, P&L & live odds. Then add crypto wallets, exchanges, DeFi & more — all in one place.

Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% free· Read-only· Encrypted